vTv plans to initiate a Phase III study for cadisegliatin with an FDA-recommende...
In the latest edition of STAT's Health Tech newsletter: pharma budget tightening...
SAN FRANCISCO, Aug. 13, 2023 — In the refrigerated grocery store aisle, meat alt...
In recent months, Getinge’s intra-aortic balloon pumps have encountered several ...
TriSalus is breaking into cancer therapeutics research with its TLR agonist SD-1...
Oxurion has received €1m ($1.09m) in funding from Atlas as part of a subscriptio...
Following the business expansion in 2022, Clinigen announced the divestment of f...
In June, Sutro received a $140m payment from Blackstone Life Sciences as part of...
Babylon, Galera and more are cutting staff, serving as a reminder that failure i...
Absci, in collaboration with Caltech, has received a grant from the Bill & Melin...
Antengene has signed a collaboration agreement with Hansoh Pharma to commerciali...
The US Food and Drug Administration (FDA) has accepted Astellas Pharma’s supplem...
City of Hope researchers are developing a chimeric antigen receptor (CAR) T cell...
The latest tag adds to three fast track designations for Reqorsa, with the compa...
One-third of hospital pharmacists say their institutions are rationing, delaying...
“I think the White House is behind the eight ball a little bit,” Community Oncol...
